abstract: The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history (Lynch Syndrome)

full free access: Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk — NEJM

CPSI (Canadian Patient Safety Institute) Bulletin

Improving Care Bulletin

This report is written about you – our partners, stakeholders, policy makers and advocates.
We want this document to speak to you and value any feedback you have as we work together to make a patient safety ripple in our healthcare system.
If you would like paper copies of this report please contact Jody White at jwhite@cpsi-icsp.ca.

• Improving Care Bulletin - January 2011
• Quarterly Update - December 2010
• Quarterly Update - August 2010
• Quarterly Update - January to April 2010

NIH summit to focus on management of radiation dose in computerized tomography, Tuesday, February 1, 2011 News Release - National Institutes of Health (NIH)

Cancer - Volume 117, Issue 3 - 1 February 2011 - Wiley Online Library (subscription required to view full text)

Note: this is the index of the most current volume with abstracts only without a subscription; numerous references to ovarian cancer

Commentary: Early versus delayed treatment of relapsed ovarian cancer : The Lancet (re: Rustin trial early vs delayed treatments/survival)

Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium

"In summary, the present analysis fails to replicate an earlier reported association of a GALNT1 variant with risk of ovarian cancer. This study highlights the need to replicate putative findings in genetic association studies."

Ovarian Metastases of Pancreaticobiliary Tract Adenocarcinomas: Analysis of 35 Cases, With Emphasis on the Ability of Metastases to Simulate Primary Ovarian Mucinous Tumors

New clinical trial to determine ovarian cancer risks in African-American women

Loss of protein could contribute to early breast and ovarian cancer deaths (protein MCPH1)

FDA review indicates possible association between breast implants and a rare cancer anaplastic large cell lymphoma (ALCL) - lymphoma

Advance Directive Language and Laws May Interfere With Patient Wishes - RWJF

The guidelines created to protect patients making end-of-life decisions may have the opposite effect. A Robert Wood Johnson Foundation Physician Faculty Scholar identifies problems and offers solutions